We are live on ! Find out more
Fidelity International

Fidelity International Portfolio holdings

AUM $129B
1-Year Est. Return 30.83%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$129B
AUM Growth
-$4.85B
Cap. Flow
-$2.09B
Cap. Flow %
-1.63%
Top 10 Hldgs %
20.63%
Holding
1,192
New
174
Increased
386
Reduced
506
Closed
87

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$897M
2
MSFT icon
Microsoft
MSFT
+$478M
3
SU icon
Suncor Energy
SU
+$444M
4
ZTS icon
Zoetis
ZTS
+$415M
5
ORCL icon
Oracle
ORCL
+$411M

Top Sells

Rank Stock Value
1
BNS icon
Scotiabank
BNS
+$546M
2
DAY
Dayforce
DAY
+$443M
3
CSCO icon
Cisco
CSCO
+$439M
4
TD icon
Toronto Dominion Bank
TD
+$406M
5
BKR icon
Baker Hughes
BKR
+$406M

Sector Composition

Rank Sector Weight
1 Technology 23.99%
2 Financials 15.79%
3 Materials 10.58%
4 Industrials 10.23%
5 Energy 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MQ icon
1076
Marqeta
MQ
$1.79B
$22.7K ﹤0.01%
+1,389
New +$23.4K
BLD
1077
DELISTED
TopBuild
BLD
$21.8K ﹤0.01%
+62
New +$27.8K
EWBC icon
1078
East-West Bancorp
EWBC
$18B
$18.3K ﹤0.01%
171
+12
+8% +$1.35K
IONS icon
1079
Ionis Pharmaceuticals
IONS
$8.85B
$12.4K ﹤0.01%
165
+118
+251% +$9.31K
EMN icon
1080
Eastman Chemical
EMN
$7.93B
$12.2K ﹤0.01%
160
+72
+82% +$5.19K
DHI icon
1081
D.R. Horton
DHI
$40.3B
$10.6K ﹤0.01%
77
-1,400
-95% -$212K
VOO icon
1082
Vanguard S&P 500 ETF
VOO
$980B
$10.2K ﹤0.01%
+17
New +$10.6K
APGE icon
1083
Apogee Therapeutics
APGE
$10.1B
$8.84K ﹤0.01%
+105
New +$7.63K
LAZ icon
1084
Lazard
LAZ
$4.28B
$8.71K ﹤0.01%
205
CGON icon
1085
CG Oncology
CGON
$6.15B
$8.53K ﹤0.01%
+126
New +$7.14K
ARCC icon
1086
Ares Capital
ARCC
$13.5B
$8.22K ﹤0.01%
456
UNF icon
1087
Unifirst Corp
UNF
$5.23B
$7.55K ﹤0.01%
30
-42,470
-100% -$9.8M
NAMS icon
1088
NewAmsterdam Pharma
NAMS
$3.72B
$6.95K ﹤0.01%
+217
New +$7.07K
NUVL
1089
DELISTED
Nuvalent
NUVL
$6.66K ﹤0.01%
+65
New +$6.62K
SMMT icon
1090
Summit Therapeutics
SMMT
$11.5B
$6.54K ﹤0.01%
+345
New +$5.58K
BBIO icon
1091
BridgeBio Pharma
BBIO
$16.1B
$6.54K ﹤0.01%
+88
New +$6.38K
MLYS icon
1092
Mineralys Therapeutics
MLYS
$2.39B
$6.2K ﹤0.01%
+229
New +$6.72K
MBX
1093
MBX Biosciences
MBX
$2.78B
$5.31K ﹤0.01%
+178
New +$6.05K
PPC icon
1094
Pilgrim's Pride
PPC
$6.77B
$4.83K ﹤0.01%
128
BNTX icon
1095
BioNTech
BNTX
$23.3B
$4.09K ﹤0.01%
+46
New +$4.73K
SES.WS icon
1096
SES AI Corp Warrants
SES.WS
$6.57M
$3.08K ﹤0.01%
94,633
BKD icon
1097
Brookdale Senior Living
BKD
$3.48B
$2.96K ﹤0.01%
+216
New +$3.03K
WIX icon
1098
WIX.com
WIX
$2.03B
$180 ﹤0.01%
2
-277,699
-100% -$23.2M
BRKR icon
1099
Bruker
BRKR
$9.08B
$108 ﹤0.01%
3
-1,610,186
-100% -$67.4M
SOLS
1100
Solstice Advanced Materials
SOLS
$9.65B
$76 ﹤0.01%
1
-7,066
-100% -$484K

Similar funds

Fidelity International's Q1 2026 Portfolio in Review

As of Q1 2026, Fidelity International held 1,192 positions worth $129B, down 3.6% from $134B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Fidelity International's Q1 2026 filing shows 174 new, 386 increased, 506 reduced and 87 closed positions. Its largest new stake was iShares US Utilities ETF: 1,827,771 shares worth $212M. The largest sale was Scotiabank, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Financials and Materials.

  • Fidelity International's largest Q1 2026 buy was iShares US Utilities ETF: 1,827,771 shares worth $212M.
  • Fidelity International added most to AstraZeneca in Q1 2026, an estimated $897M increase.
  • Fidelity International's biggest Q1 2026 reduction was Scotiabank, cutting an estimated $546M.
  • Fidelity International fully exited Dayforce in Q1 2026, selling an estimated $443M.
  • Fidelity International's ten largest holdings make up 21% of its $129B portfolio in Q1 2026.
  • Fidelity International opened 174 new positions and closed 87 in Q1 2026.
  • Fidelity International's portfolio value fell 3.6% quarter-over-quarter to $129B.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.